BioSpace News Archive

Somatus will deliver a presentation entitled “A United Front – Serving the Underserved Together” at the National Kidney (NKF) Foundation Spring Clinical Conference.

TTG Imaging Solutions, LLC a leader in nuclear medicine and molecular imaging equipment sales and service, and the largest U.S. sales & service partner for Medical Imaging Electronics’ ANCORIS is pleased to announce the first U.S. installation of the ANCORIS, at the California Heart and Vascular Clinic in El Centro, California.

Foghorn® Therapeutics Inc. announced upcoming oral presentations highlighting its transcription factor and protein degradation capabilities at the 18th Annual Drug Discovery Chemistry Meeting.

Codexis, Inc., a leading enzyme engineering company, announced the approval of equity grants to two new employees as approved by the Compensation Committee of Codexis’s Board of Directors.

Affimed N.V. announced that it has received a written notice, dated April 4, 2023, from the Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that, for the last thirty consecutive business days, the bid price for the Company’s common shares had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5550.

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced the grant of stock options to purchase 17,000 shares of its common stock to one new employee.

Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that its Chief Medical Officer (CMO) Mark Gelder, M.D., recently passed away unexpectedly.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, presented data from its live virus vaccine platform development program in two oral presentations at the World Vaccine Congress being held in Washington D.C., April 3-6, 2023.

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2023 financial results after the market closes on Thursday, May 4, 2023.

AbCellera (Nasdaq: ABCL) will announce its first quarter 2023 financial results on Thursday, May 4, 2023, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.